Overactive bladder: onabotulinumtoxinA as treatment

Online course on effective management of pathophysiological conditions affecting the lower urine tract (overactive bladder and neurogenic detrusor overactivity).

 

Learning Objectives

OnabotulinumtoxinA clinical data

Chapter 1: What is onabotulinumtoxinA?

  • Gain a background on onabotulinumtoxinA: the molecule, and its applications in a variety of disease indications

 Chapter 2: How does onabotulinumtoxinAwork in the bladder?

  • Gain a detailed understanding of how onabotulinumtoxinA works in the bladder
  • Understand the sensorimotor action of onabotulinumtoxinA in OAB and NDO

 Chapter 3: Evidence for onabotulinumtoxinA in OAB

  • Understand the efficacy and safety profile of onabotulinumtoxinA for OAB
  • Understand the impact on QoL for patients with OAB who receive onabotulinumtoxinA injections

 Chapter 4: Evidence for onabotulinumtoxinA in NDO

  • Understand the efficacy and safety profile of onabotulinumtoxinA for NDO
  • Understand the QoL impact of onabotulinumtoxinA for patients with NDO

OnabotulinumtoxinA in practice

Chapter 1: Practical considerations before treatment

  • Explore who is eligible for onabotulinumtoxinA therapy
  • Understand the equipment needed and preparations required before treating a patient with onabotulinumtoxinA
  • Understand other practical considerations that you need to have addressed before administering onabotulinumtoxinA

Chapter 2: Administration in OAB

  • Understand all procedural considerations for onabotulinumtoxinA administration in OAB, whether you are a first time or repeat injector conducting your work in an office or a theatre

Chapter 3: Administration in NDO

  • Understand how to prepare onabotulinumtoxinA using two 100 Unit vials for NDO
  • Understand how to prepare onabotulinumtoxinA using one 200 Unit vial for NDO

Chapter 4: Aftercare and re-treatment

  • Understand what is required post-treatment in order to ensure your patients receive the best possible care
  • Review when re-treatment should be considered according to clinical trial data

Chapter 5: A fully informed patient

  • Learn how to appropriately educate patients about onabotulinumtoxinA: the product and the procedure
  • Learn ways of allaying patients’ potential anxieties and misconceptions about onabotulinumtoxinA
  • Understand how to guide patients’ expectations in terms of efficacy and potential side effects

Chapter 6: Setting up an onabotulinumtoxinA service

  • Understand the practical considerations for setting up an onabotulinumtoxinA service
  • Understand the steps required to secure funding for your service
  • Understand how to develop an implementation plan for your service

Learning Modules

Module 1: OnabotulinumtoxinA clinical data

  • Chapter 1: What is onabotulinumtoxinA?
  • Chapter 2: How does onabotulinumtoxinAwork in the bladder?
  • Chapter 3: Evidence for onabotulinumtoxinA in OAB
  • Chapter 4: Evidence for onabotulinumtoxinA in NDO

Module 2: OnabotulinumtoxinA in practice

  • Chapter 1: Practical considerations before treatment
  • Chapter 2: Administration in OAB
  • Chapter 3: Administration in NDO
  • Chapter 4: Aftercare and re-treatment
  • Chapter 5: A fully informed patient
  • Chapter 6: Setting up an onabotulinumtoxinA service

At a glance

  • Publication date: March 2015
  • Available languages: English
  • Duration: Approx. 120 minutes
  • Target group: junior or senior urologists
  • Topic: OAB and NDO
  • CME: 2 European CME credits (ECMEC)

Adobe Flash Player is required for this module. This e-course is not compatible with tablets.